ACTIVE

NYOTA INVEST

Financial year 2025 · Closed on 31/12/2025

Net result707,1 k €+41 688,5 %over 1 year
Gross margin-936,6 €+23,9 %over 1 year
Equity8,6 M €+9,0 %over 1 year

Identity

Source · BCE/KBO

NYOTA INVEST is a Public limited company incorporated in 2013. Its main activity is: Other financial service activities, except insurance and pension funding n.e.c.. Its registered office is in Schaerbeek.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0502.895.411
Incorporation
30/01/2013
Legal form
Public limited company
Registered office
Boulevard Général Wahis 20a
1030 Schaerbeek · BruxellesSee on map
Contributed capital
3 080 000,00 €
Latest accounts
31/12/2025
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskPositive cashflow

Financials

Source · NBB, 13 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin-936,6 €-1,2 k €-4,1 k €-860 €-3 k €
EBITDA-3,2 k €-1,5 k €-5,9 k €-1,9 k €-4,4 k €
Operating result-3,2 k €-1,5 k €-5,9 k €-1,9 k €-4,4 k €
Net result707,1 k €-1,7 k €323,6 k €396,8 k €994,3 k €
Balance sheet
Equity8,6 M €7,9 M €7,9 M €8,9 M €8,6 M €
Total assets8,6 M €7,9 M €7,9 M €9 M €8,6 M €
Cash712,2 k €9,5 k €1,5 k €1,4 M €1 M €
Debts–1,1 k €1,1 k €1,1 k €1,1 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 3 ended

Active mandates

Jean-Pierre DELEGLISE

Director

Active
PHILIPPE MARECHAL

Managing director

Active
SERGE DASSAS

Director

Active

Ended mandates

Jean-Pierre DELEGLISE

Director · since 18 janvier 2013 · until 01 mai 2019

Ended
PHILIPPE MARECHAL

Managing director · since 18 janvier 2013 · until 01 mai 2019

Ended
SERGE DASSAS

Director · since 18 janvier 2013 · until 01 mai 2019

Ended

Other companies at this address

Boulevard Général Wahis 20a 1030 Schaerbeek
CompanyCBE no.
ALPHA PRIME● Active
0448.698.244
IBIS PHARMA● Active
0448.505.234
0464.465.890

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelAbridged modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date05/06/202627/05/202524/07/202422/05/202304/07/202211/06/2021
General meeting05/05/202606/05/202507/05/202402/05/202303/05/202204/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 13 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202505/05/202605/06/2026FrenchPDF
Micro model31/12/202406/05/202527/05/2025FrenchPDF
Micro model31/12/202307/05/202424/07/2024FrenchPDF
Abridged model31/12/202202/05/202322/05/2023FrenchPDF
Micro model31/12/202103/05/202204/07/2022FrenchPDF
Micro model31/12/202004/05/202111/06/2021FrenchPDF
Abridged model31/12/201905/05/202010/07/2020FrenchPDF
Abridged model31/12/201807/05/201927/08/2019FrenchPDF
Micro model31/12/201702/05/201830/08/2018FrenchPDF
Abridged model31/12/201602/05/201729/08/2017FrenchPDF
Full model31/12/201503/05/201613/07/2016FrenchPDF
Full model31/12/201405/05/201531/08/2015FrenchPDF
Full model31/12/201306/05/201421/08/2014FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 3 ended

Active mandates

Jean-Pierre DELEGLISE

Director

Active
PHILIPPE MARECHAL

Managing director

Active
SERGE DASSAS

Director

Active

Ended mandates

Jean-Pierre DELEGLISE

Director · since 18 janvier 2013 · until 01 mai 2019

Ended
PHILIPPE MARECHAL

Managing director · since 18 janvier 2013 · until 01 mai 2019

Ended
SERGE DASSAS

Director · since 18 janvier 2013 · until 01 mai 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares07/04/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates09/10/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares24/01/2023
    CAPITAL, ACTIONS
    PDF
  • Capital / shares22/03/2021
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates27/02/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares30/07/2018
    CAPITAL, ACTIONS
    PDF
  • Capital / shares07/12/2017
    CAPITAL, ACTIONS
    PDF
  • Other18/03/2013
    DIVERS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025707,1 k €↑
  2. 2024
    Annual accounts 2024-1,7 k €↓
  3. 2023
    Annual accounts 2023323,6 k €↓
  4. 2022
    Annual accounts 2022396,8 k €↓
  5. 2021
    Annual accounts 2021994,3 k €↓
  6. 2020
    Annual accounts 20201 M €↑
  7. 2019
    Annual accounts 2019-2,4 k €↓
  8. 2018
    Annual accounts 2018-1,9 k €↓
  9. 2017
    Annual accounts 20172,1 M €↑
  10. 2016
    Annual accounts 2016-6,8 k €↑
  11. 2015
    Annual accounts 2015-6,8 k €↓
  12. 2014
    Annual accounts 2014-6,6 k €↑
  13. 2013
    Annual accounts 2013-9,4 k €
  14. 30/01/2013
    IncorporationPublic limited company